Jagsonpal Pharmaceuticals standalone net profit rises 0.16% in the September 2026 quarter

Sales rise 9.28% to Rs 81.38 crore

Net profit of Jagsonpal Pharmaceuticals rose 0.16% to Rs 12.59 crore in the quarter ended September 2026 as against Rs 12.57 crore during the previous quarter ended September 2025. Sales rose 9.28% to Rs 81.38 crore in the quarter ended September 2026 as against Rs 74.47 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	81.38	74.47	9
OPM %	20.61	22.08	-
PBDT	18.75	19.20	-2
PBT	17.07	16.81	2
NP	12.59	12.57	0

Powered by Capital Market - Live News